These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 17688663
1. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience. Mishra P, Desai N, Alexander J, Singh DP, Sawant P. J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663 [Abstract] [Full Text] [Related]
2. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients? Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R. Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344 [Abstract] [Full Text] [Related]
3. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis. Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R. Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560 [Abstract] [Full Text] [Related]
4. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis. Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ. J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416 [Abstract] [Full Text] [Related]
5. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473 [Abstract] [Full Text] [Related]
6. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure. Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY. Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172 [Abstract] [Full Text] [Related]
7. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month]. Bae WK, Lee JS, Kim NH, Kim KA, Moon YS, Oh MK. Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075 [Abstract] [Full Text] [Related]
8. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353 [Abstract] [Full Text] [Related]
9. MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver. Shaikh S, Ghani H, Memon S, Baloch GH, Jaffery M, Shaikh K. J Coll Physicians Surg Pak; 2010 Jul; 20(7):432-5. PubMed ID: 20642940 [Abstract] [Full Text] [Related]
10. Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection. Khan R, Abid S, Jafri W, Awan S, Hamid S, Shah H, Pervez S. J Coll Physicians Surg Pak; 2009 Nov; 19(11):694-8. PubMed ID: 19889264 [Abstract] [Full Text] [Related]
11. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis]. Jiang ZS, Jiang JN. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709 [Abstract] [Full Text] [Related]
12. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score]. Lee DH, Son JH, Kim TW. Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034 [Abstract] [Full Text] [Related]
13. Do chronic liver disease scoring systems predict outcomes in trauma patients with liver disease? A comparison of MELD and CTP. Seamon MJ, Franco MJ, Stawicki SP, Smith BP, Kulp H, Goldberg AJ, Santora TA, Gaughan JP. J Trauma; 2010 Sep; 69(3):568-73. PubMed ID: 20838128 [Abstract] [Full Text] [Related]
14. Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant. Bazarah SM, Peltekian KM, McAlister VC, Bitter-Suermann H, MacDonald AS. Clin Invest Med; 2004 Aug; 27(4):162-7. PubMed ID: 15453152 [Abstract] [Full Text] [Related]
15. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B. Chan HL, Chim AM, Lau JT, Hui AY, Wong VW, Sung JJ. Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555 [Abstract] [Full Text] [Related]
16. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey. Huo TI, Lin HC, Hsia CY, Wu JC, Lee PC, Chi CW, Lee SD. Am J Gastroenterol; 2007 Sep; 102(9):1920-30. PubMed ID: 17573792 [Abstract] [Full Text] [Related]
17. Assessing the short- and long-term prognosis of patients with cirrhosis and acute variceal bleeding. Sempere L, Palazón JM, Sánchez-Payá J, Pascual S, de Madaria E, Poveda MJ, Carnicer F, Zapater P, Pérez-Mateo M. Rev Esp Enferm Dig; 2009 Apr; 101(4):236-48. PubMed ID: 19492899 [Abstract] [Full Text] [Related]
18. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Farnsworth N, Fagan SP, Berger DH, Awad SS. Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574 [Abstract] [Full Text] [Related]
19. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, Choudhuri G. Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864 [Abstract] [Full Text] [Related]
20. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Huo TI, Lin HC, Huang YH, Wu JC, Chiang JH, Lee PC, Lee SD. Cancer; 2006 Jul 01; 107(1):141-8. PubMed ID: 16708358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]